The first-ever Thomson Reuters Intellectual Property Solutions User Conference was hosted by the GGO China Intellectual Property & Science team in Suzhou in October, drawing more than 70 attendees, including corporate Research & Development (R&D) and intellectual property (IP) managers, as well as patent researchers and librarians from government agencies. Seventy-three percent of the participants were at the manager level or above.
Linda Guo, Managing Director of GGO China IP & Science and Chunqi Liu, Director of the Suzhou IP Office, delivered opening speeches. A wide array of topics were covered at the event, ranging from the strategic value of patent information for decision making in corporate settings and for economic growth, to IP management best practices, to early warnings of patent infringement risks, to how IP can support corporate competitiveness in the global market.
Presenters included industry thought leader Dr. Yuefeng He from the China Patent Office (SIPO); lead users from Dow Chemical, Beiqi Foton, Sany Heavy Industrial Co., Ltd, and China Aerospace Sci. & Tech. Corp.; and Thomson Reuters managers and experts, including Tim White, Fan Zhang, Weiping Yue, Bean Peng, and Herman An. The speeches were well received and followed by active question and answer sessions, which included several questions around IP management services.
“This conference helped us build closer relationships with our customers and further develop our active user community,” explained event organizer Victoria Wang. “The event was a success thanks to strong teamwork, especially from the sales teams and our solution specialists, who contributed case studies from our Asia Pacific colleagues and the IP&S team in the U.S.”
Our IP & Science business provides information-based solutions on patents, trademarks and standards. Having entered the Chinese market in 1999, IP & Science now provides Thomson Innovation, Thomson Data Analyzer and IP services that are used by R&D, IP and intelligence professionals in 394 Chinese accounts, including 92 corporate, 61 pharmaceutical companies, 37 government institutes and 204 universities. The largest customer of IP&S in China is the State IP Office (SIPO), where patent examiners search DWPI to assess the novelty of inventions.